Skip to main content
Equibles

ALBION FINANCIAL GROUP /UT

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1054677 SALT LAKE CITY, UT
Back to TMO Full portfolio

Position in TMO

as of Jun 30, 2026 · filed Jul 22, 2026
Position Value
$12,113,860
+$155,919 QoQ
Shares Held
24,162
-0.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.25%
of 13F equity value
Holder Rank
#608
of 2,620 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

ALBION FINANCIAL GROUP /UT holds $13,727,883 across 8 Diagnostics & Research names. TMO ranks #1 (88.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
This page 		24,162 $12,113,860
2 A
Agilent Technologies, Inc.
 10,160 $1,349,552
3 DHR
Danaher Corp /De/
 1,290 $245,719
4 IDXX
Idexx Laboratories Inc /De
 21 $11,055
5 WAT
Waters Corp /De/
 15 $5,625
6 LH
Labcorp Holdings Inc.
 6 $1,680
7 ILMN
Illumina, Inc.
 2 $351
8 IMDX
Insight Molecular Diagnostics Inc.
 7 $41

All Filings in TMO

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,113,860 24,162
2026-03-31 $11,957,941 24,328
2025-12-31 $14,138,580 24,400
2025-09-30 $12,140,050 25,030
2025-06-30 $10,333,959 25,487
2025-03-31 $12,723,632 25,570
2024-12-31 $13,361,587 25,684
2024-09-30 $16,121,171 26,062
2024-06-30 $14,375,235 25,995
2024-03-31 $15,214,334 26,177
2023-12-31 $13,963,492 26,307
2023-09-30 $13,300,629 26,277
2023-06-30 $13,520,107 25,913
2023-03-31 $15,609,252 27,082
2022-12-31 $15,294,313 27,773
2022-09-30 $14,042,062 27,686
2022-06-30 $15,073,303 27,745
2022-03-31 $16,208,617 27,442
2021-12-31 $17,306,203 25,937
2021-09-30 $13,879,891 24,294
2021-06-30 $12,223,812 24,231
2020-12-31 $9,822,368 21,088
2020-09-30 $6,518,601 14,764